/AVCR.V
AVCR.V Stock - Avricore Health Inc.
Healthcare|Medical - Diagnostics & ResearchTSXV
$0.05+0.00%
+$0.00 (+0.00%) • Dec 18
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.17
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.06
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AVCR.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.05 – $0.05
TARGET (TP)$0.06
STOP LOSS$0.05
RISK/REWARD1:Infinity
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.06
52W High$0.09
52W Low$0.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.79M | $3.49M | $1.77M | $122,808 | $33,030 |
| Gross Profit | $1.88M | $1.20M | $456,793 | $30,521 | $17,480 |
| Gross Margin | 39.3% | 34.5% | 25.8% | 24.9% | 52.9% |
| Operating Income | $139,348 | $-691,839 | $-809,859 | $-1,745,008 | $-859,154 |
| Net Income | $-668,977 | $-701,215 | $-818,228 | $-1,708,132 | $-1,173,966 |
| Net Margin | -14.0% | -20.1% | -46.3% | -1390.9% | -3554.2% |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.02 |
Company Overview
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AVCR.VBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 28, 2026 | — | — | — | — |
Q4 2025 | Dec 1, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 28, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 28, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 2, 2024 | — | $-0.01 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 29, 2024 | — | $0.00 | — | — |
Q2 2024 | Apr 30, 2024 | — | $0.00 | — | — |
Q4 2023 | Nov 30, 2023 | — | $0.00 | — | — |
Q4 2023 | Nov 29, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 2, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q4 2022 | Nov 29, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AVCR.V
What is AVCR.V's current stock price?
Avricore Health Inc. (AVCR.V) is currently trading at $0.05 per share. The stock has moved +0.00% today.
What is the analyst price target for AVCR.V?
No analyst price targets are currently available for this stock.
What sector is Avricore Health Inc. in?
Avricore Health Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the TSXV exchange.
What is AVCR.V's market cap?
Avricore Health Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does AVCR.V pay dividends?
No, Avricore Health Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPS.TO
Aptose Biosciences Inc.
$2.08
Mkt Cap: $0.0B
CANB.V
CanadaBis Capital Inc.
$0.03
Mkt Cap: $0.0B
CDVA.CN
CordovaCann Corp.
$0.04
Mkt Cap: $0.0B
KNE.V
Kane Biotech Inc.
$0.04
Mkt Cap: $0.0B
MUSH.V
Mercanto Holdings Inc.
$0.14
Mkt Cap: $0.0B
MVMD.CN
Mountain Valley MD Holdings Inc.
$0.01
Mkt Cap: $0.0B
RVV.CN
Revive Therapeutics Ltd.
$0.01
Mkt Cap: $0.0B
TELO.V
Telo Genomics Corp.
$0.06
Mkt Cap: $0.0B
TGIF.CN
1933 Industries Inc.
$0.01
Mkt Cap: $0.0B
THRM.V
Therma Bright Inc.
$0.05
Mkt Cap: $0.0B
Explore stocks similar to AVCR.V for comparison